have subdivided breast cancer into four main clinical subtypes, according to gene expression profiles and receptor status (oestrogen receptor [ER], progestogen receptor [PR] and human epidermal growth factor receptor 2 [Her‐2]), as well as proliferation status10 assessed by Ki67.14 This evidence concerns the gene MKI67 and breast carcinoma.